165 related articles for article (PubMed ID: 10350395)
21. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B.
Alioglu B; Avci Z; Canan O; Ozcay F; Demirhan B; Ozbek N
Pediatr Hematol Oncol; 2007; 24(1):63-8. PubMed ID: 17130115
[TBL] [Abstract][Full Text] [Related]
22. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
[TBL] [Abstract][Full Text] [Related]
23. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
24. Nanosomal Amphotericin B is an efficacious alternative to Ambisome for fungal therapy.
Sheikh S; Ali SM; Ahmad MU; Ahmad A; Mushtaq M; Paithankar M; Mandal J; Saptarishi D; Sehgal A; Maheshwari K; Ahmad I
Int J Pharm; 2010 Sep; 397(1-2):103-8. PubMed ID: 20621173
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
26. Liposomal amphotericin B (AmBisome): efficacy and safety of low-dose therapy in pulmonary fungal infections.
Lequaglie C
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():49-50. PubMed ID: 11801581
[TBL] [Abstract][Full Text] [Related]
27. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
Lionakis MS; Lewis RE; Chamilos G; Kontoyiannis DP
Pharmacotherapy; 2005 Sep; 25(9):1174-80. PubMed ID: 16164392
[TBL] [Abstract][Full Text] [Related]
28. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.
Ringdén O; Meunier F; Tollemar J; Ricci P; Tura S; Kuse E; Viviani MA; Gorin NC; Klastersky J; Fenaux P
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():73-82. PubMed ID: 1778894
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.
Ozsahin H; von Planta M; Müller I; Steinert HC; Nadal D; Lauener R; Tuchschmid P; Willi UV; Ozsahin M; Crompton NE; Seger RA
Blood; 1998 Oct; 92(8):2719-24. PubMed ID: 9763555
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of tongue aspergillosis caused by Aspergillus flavus with liposomal amphotericin B in a child with acute lymphoblastic leukemia.
Bor O; Cagri Dinleyici E; Kiraz N; Dundar E; Akdeniz Akgun N
Med Mycol; 2006 Dec; 44(8):767-70. PubMed ID: 17127634
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal amphotericin B and itraconazole.
Streppel M; Bachmann G; Arnold G; Damm M; Stennert E
Ann Otol Rhinol Laryngol; 1999 Feb; 108(2):205-7. PubMed ID: 10030242
[TBL] [Abstract][Full Text] [Related]
33. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
Lass-Flörl C; Kofler G; Kropshofer G; Hermans J; Kreczy A; Dierich MP; Niederwieser D
J Antimicrob Chemother; 1998 Oct; 42(4):497-502. PubMed ID: 9818749
[TBL] [Abstract][Full Text] [Related]
34. [Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B].
Suárez Ortega S; Campos-Herrero Navas MI; Limeres González MA; Díaz López F; Zarzalejos Andes JM; Arkuch Saade ME
An Med Interna; 2004 Jan; 21(1):20-2. PubMed ID: 15195481
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2004 Feb; 53(2):311-7. PubMed ID: 14729753
[TBL] [Abstract][Full Text] [Related]
36. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
Med Mycol; 2013 Feb; 51(2):155-63. PubMed ID: 22800082
[TBL] [Abstract][Full Text] [Related]
37. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
Ng TT; Denning DW
Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054
[TBL] [Abstract][Full Text] [Related]
38. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients.
Mills W; Chopra R; Linch DC; Goldstone AH
Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068
[TBL] [Abstract][Full Text] [Related]
39. Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient.
Vianna R; Misra V; Fridell JA; Goldman M; Mangus RS; Tector J
Transplant Proc; 2007; 39(1):305-7. PubMed ID: 17275530
[TBL] [Abstract][Full Text] [Related]
40. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
Palacio C; Acebedo G; López A; Jodar JM
Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
